{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:48:19Z","timestamp":1789721299346,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bmcl.2021.128122","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T12:00:19Z","timestamp":1621252819000},"page":"128122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates"],"prefix":"10.1016","volume":"45","author":[{"given":"Weiwei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangman","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2156-7271","authenticated-orcid":false,"given":"Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128122_b0005","doi-asserted-by":"crossref","unstructured":"Willyard, C., The drug-resistant bacteria that pose the greatest health threats. Nature 2017, 543 (7643), 15-15.","DOI":"10.1038\/nature.2017.21550"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128122_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bmcl.2021.128122_b0015","unstructured":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; World Health Organization: Geneva, 2018; https:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/."},{"issue":"3","key":"10.1016\/j.bmcl.2021.128122_b0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti. Infect. Ther."},{"issue":"9","key":"10.1016\/j.bmcl.2021.128122_b0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ja.2014.111","article-title":"Glycopeptide antibiotics: back to the future","volume":"67","author":"Butler","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"31","key":"10.1016\/j.bmcl.2021.128122_b0030","doi-asserted-by":"crossref","first-page":"9314","DOI":"10.1021\/ja035901x","article-title":"Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions","volume":"125","author":"Mccomas","year":"2003","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.bmcl.2021.128122_b0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in Glycopeptide Antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"6","key":"10.1016\/j.bmcl.2021.128122_b0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","article-title":"Antibiotics in the clinical pipeline in October 2019","volume":"73","author":"Butler","year":"2020","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128122_b0045","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1021\/acs.jmedchem.8b01093","article-title":"Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies","volume":"62","author":"Dhanda","year":"2019","journal-title":"J. Med. Chem."},{"issue":"49","key":"10.1016\/j.bmcl.2021.128122_b0050","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1074\/jbc.REV119.006349","article-title":"Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics","volume":"294","author":"Marschall","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/j.bmcl.2021.128122_b0055","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1021\/jacs.8b08711","article-title":"A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells","volume":"140","author":"Antonoplis","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.bmcl.2021.128122_b0060","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/acschembio.9b00565","article-title":"Vancomycin-Arginine Conjugate Inhibits Growth of Carbapenem-Resistant E. coli and Targets Cell-Wall Synthesis","volume":"14","author":"Antonoplis","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bmcl.2021.128122_b0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-017-02123-w","article-title":"Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria","volume":"9","author":"Blaskovich","year":"2018","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.bmcl.2021.128122_b0070","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1002\/anie.202002727","article-title":"Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides","volume":"59","author":"Umstatter","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"10.1016\/j.bmcl.2021.128122_b0075","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/jm500270w","article-title":"Membrane active vancomycin analogues: a strategy to combat bacterial resistance","volume":"57","author":"Yarlagadda","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bmcl.2021.128122_b0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acsinfecdis.5b00114","article-title":"Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria","volume":"2","author":"Yarlagadda","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.bmcl.2021.128122_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cb0500015","article-title":"Redefining the requisite lipopolysaccharide structure in Escherichia coli","volume":"1","author":"Meredith","year":"2006","journal-title":"ACS Chem. Bio."},{"issue":"5","key":"10.1016\/j.bmcl.2021.128122_b0090","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure\u2013activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bmcl.2021.128122_b0095","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1128\/AAC.48.9.3349-3357.2004","article-title":"novo design of potent antimicrobial peptides","volume":"48","author":"Frecer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"7787","key":"10.1016\/j.bmcl.2021.128122_b0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-019-1665-6","article-title":"Chimeric peptidomimetic antibiotics against Gram-negative bacteria","volume":"576","author":"Luther","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128122_b0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijmm.2007.03.002","article-title":"Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae","volume":"297","author":"Pramanik","year":"2007","journal-title":"Int. J. Med. Microbiol."},{"issue":"51","key":"10.1016\/j.bmcl.2021.128122_b0110","doi-asserted-by":"crossref","first-page":"21310","DOI":"10.1021\/jacs.0c06987","article-title":"Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates","volume":"142","author":"Boyce","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.bmcl.2021.128122_b0115","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bbamem.2006.04.006","article-title":"Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action","volume":"1758","author":"Chan","year":"2006","journal-title":"Biochim. Biophys. Acta."},{"issue":"6","key":"10.1016\/j.bmcl.2021.128122_b0120","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1128\/IAI.67.6.2790-2796.1999","article-title":"Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS","volume":"67","author":"de Haas","year":"1999","journal-title":"Infect. Immun."},{"issue":"5093","key":"10.1016\/j.bmcl.2021.128122_b0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.8420003","article-title":"Molecular mapping and detoxification of the lipid A binding site by synthetic peptides","volume":"259","author":"Rustici","year":"1993","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.bmcl.2021.128122_b0130","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1021\/bi800450f","article-title":"Parameters Involved in Antimicrobial and Endotoxin Detoxification Activities of Antimicrobial Peptides","volume":"47","author":"Rosenfeld","year":"2008","journal-title":"Biochem"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128122_b0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.164.2.549","article-title":"Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein","volume":"164","author":"Scott","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bmcl.2021.128122_b0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41570-019-0079-1","article-title":"Contemporary approaches to site-selective protein modification","volume":"3","author":"Hoyt","year":"2019","journal-title":"Nat Rev Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128122_b0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/acs.jmedchem.7b01345","article-title":"Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci","volume":"61","author":"Guan","year":"2018","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.bmcl.2021.128122_b0150","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1002\/anie.201902210","article-title":"Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug-Resistant Bacteria","volume":"58","author":"Guan","year":"2019","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21003486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21003486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:41:00Z","timestamp":1760773260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21003486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S0960894X21003486"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128122","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128122"}}